Spinal muscular atrophy (SMA) is one of 7,000 rare diseases. It is the second-most common autosomal recessive disease in humans and the number one genetic cause of death…
Physicians can be considered medical artists, so Australian scientists are developing an advanced "paintbrush" for surgeons specializing in arthritis and joint replacements.
Prolaris is a prostate-specific antigen (PSA) genetic test that analyzes cancer cells of patients diagnosed with prostate cancer. The test determines the aggressiveness of the cancer, helping physicians…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Sequencing an individual patient’s genome is no longer cost prohibitive. Physicians can use this information to develop custom-tailored treatments that have shown efficacy in other patients with similar…
There have been many advancements in chemotherapy and immunotherapy treatments for various cancers over the past decade, but the 5-year relative survival rate for glioblastoma patients is still…
A new method of coaxing adult cells into iMS cells may be safer, more versatile, and more effective than current, experimental embryonic stem cell processes.
